Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK-STAT signaling in macrophages by perturbing lipid raft structures.
STAT
arachidonic acid
interferon
lipid rafts
macrophage
ovarian cancer microenvironment
Journal
Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
29
03
2022
received:
07
10
2021
accepted:
20
04
2022
pubmed:
23
4
2022
medline:
9
9
2022
entrez:
22
4
2022
Statut:
ppublish
Résumé
Survival of ovarian carcinoma is associated with the abundance of immunosuppressed CD163
Identifiants
pubmed: 35451191
doi: 10.1002/1878-0261.13221
pmc: PMC9441005
doi:
Substances chimiques
STAT1 Transcription Factor
0
Arachidonic Acid
27YG812J1I
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3146-3166Informations de copyright
© 2022 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
Pathol Int. 2009 May;59(5):300-5
pubmed: 19432671
J Biol Chem. 2002 Apr 5;277(14):12067-74
pubmed: 11815625
Cell Signal. 1995 Mar;7(3):171-84
pubmed: 7662506
Metabolites. 2012 Feb 20;2(1):195-213
pubmed: 24957374
Oncol Rep. 2005 Jun;13(6):1153-8
pubmed: 15870936
Front Oncol. 2017 Feb 22;7:24
pubmed: 28275576
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
J Immunol. 2012 Jan 1;188(1):21-8
pubmed: 22187483
Cell Mol Life Sci. 2015 Feb;72(3):557-581
pubmed: 25332099
J Biol Chem. 2003 Feb 21;278(8):5794-801
pubmed: 12482878
Genome Biol. 2016 May 23;17(1):108
pubmed: 27215396
Immunobiology. 2017 Jan;222(1):75-81
pubmed: 26876591
J Biol Chem. 2001 Oct 5;276(40):37335-40
pubmed: 11489905
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Biochemistry. 2003 Apr 22;42(15):4485-91
pubmed: 12693944
BMC Genomics. 2017 Mar 21;18(1):243
pubmed: 28327095
N Engl J Med. 2003 Jan 16;348(3):203-13
pubmed: 12529460
Mol Pharmacol. 2008 Nov;74(5):1269-77
pubmed: 18701617
J Interferon Cytokine Res. 2016 Jan;36(1):62-73
pubmed: 26430781
Nat Rev Cancer. 2016 Mar;16(3):131-44
pubmed: 26911188
BMC Bioinformatics. 2008 Jul 30;9:326
pubmed: 18667053
J Clin Oncol. 1996 Feb;14(2):343-50
pubmed: 8636742
Mol Immunol. 2009 May;46(8-9):1867-77
pubmed: 19299019
Front Immunol. 2018 Jun 27;9:1425
pubmed: 29997615
Methods Mol Biol. 2021;2187:147-186
pubmed: 32770506
Oncotarget. 2015 Nov 24;6(37):40005-25
pubmed: 26503466
Braz J Med Biol Res. 2003 Nov;36(11):1549-60
pubmed: 14576910
Blood. 1996 Nov 15;88(10):3792-800
pubmed: 8916943
Oncoimmunology. 2017 Aug 21;6(9):e1339854
pubmed: 28932639
Gynecol Oncol. 2006 Jan;100(1):133-8
pubmed: 16153694
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Biol Chem. 2014 Sep 5;289(36):24874-84
pubmed: 25056956
JAKSTAT. 2012 Oct 1;1(4):241-9
pubmed: 24058779
Oncoimmunology. 2015 Jan 23;4(3):e994446
pubmed: 25949921
Cell. 2006 Jan 27;124(2):263-6
pubmed: 16439202
Mol Cell Proteomics. 2019 Aug;18(8):1700-1702
pubmed: 31097673
Physiol Rev. 2020 Jan 1;100(1):171-210
pubmed: 31487233
J Lipid Res. 2012 Nov;53(11):2343-54
pubmed: 22949356
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Lipids. 1979 Feb;14(2):181-93
pubmed: 106197
Am J Obstet Gynecol. 2004 Nov;191(5):1598-605
pubmed: 15547530
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
J Neurosci. 1993 Oct;13(10):4361-71
pubmed: 8410192
Nat Rev Mol Cell Biol. 2008 Feb;9(2):162-76
pubmed: 18216772
Theranostics. 2021 Jan 1;11(3):1377-1395
pubmed: 33391540
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
J Pharm Pharmacol. 2000 May;52(5):539-46
pubmed: 10864142
Oncotarget. 2015 May 30;6(15):13416-33
pubmed: 25968567
PLoS Pathog. 2011 Sep;7(9):e1002229
pubmed: 21931549
Int J Mol Sci. 2019 Feb 15;20(4):
pubmed: 30781344
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43
pubmed: 16344461
Nat Med. 2004 Sep;10(9):942-9
pubmed: 15322536
Nat Med. 2015 Jul;21(7):719-29
pubmed: 26121196
Cancer Metastasis Rev. 2018 Sep;37(2-3):347-354
pubmed: 29926309
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):18-26
pubmed: 17197511
Cancer Res. 1990 Nov 15;50(22):7318-23
pubmed: 2121337
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8517-22
pubmed: 22586114
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Front Immunol. 2019 Oct 22;10:2388
pubmed: 31695691
J Biol Chem. 2001 Jul 6;276(27):24743-50
pubmed: 11328812
Endocrinology. 2004 Feb;145(2):613-9
pubmed: 14563701
Exp Mol Med. 2018 Sep 21;50(9):1-10
pubmed: 30242145
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Immunology. 2016 Sep;149(1):13-24
pubmed: 27153983
Br J Cancer. 2000 Mar;82(6):1138-44
pubmed: 10735496
Front Oncol. 2020 Nov 03;10:590941
pubmed: 33224886
J Cell Sci. 1997 Jul;110 ( Pt 14):1625-34
pubmed: 9247196
Mol Cell Proteomics. 2018 Feb;17(2):270-289
pubmed: 29141914
Science. 2000 Jun 30;288(5475):2357-60
pubmed: 10875919
Int J Cancer. 2014 Jan 1;134(1):32-42
pubmed: 23784932
Oncoimmunology. 2018 Mar 15;7(5):e1424672
pubmed: 29721385
J Invest Dermatol. 2002 Apr;118(4):582-8
pubmed: 11918702
J Biol Chem. 2009 Oct 2;284(40):27384-92
pubmed: 19648648
Blood. 2010 Apr 15;115(15):3109-17
pubmed: 20130243
Am J Physiol Cell Physiol. 2003 Aug;285(2):C399-408
pubmed: 12686512
Int J Cancer. 2009 May 15;124(10):2353-60
pubmed: 19170204
FASEB J. 2004 Jun;18(9):1040-2
pubmed: 15084525
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
Front Immunol. 2020 May 15;11:940
pubmed: 32499786